Patent 10335369 was granted and assigned to Novo Nordisk on July, 2019 by the United States Patent and Trademark Office.
The invention relates to granules and pharmaceutical compositions comprising a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant obtained by mixing hereof for more than 5 minutes prior to granulation as well as processes for their preparation and use thereof in medicine.